These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 16489076

  • 1. Significance of skp2 expression in primary breast cancer.
    Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M.
    Clin Cancer Res; 2006 Feb 15; 12(4):1215-20. PubMed ID: 16489076
    [Abstract] [Full Text] [Related]

  • 2. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
    Masuda TA, Inoue H, Sonoda H, Mine S, Yoshikawa Y, Nakayama K, Nakayama K, Mori M.
    Cancer Res; 2002 Jul 01; 62(13):3819-25. PubMed ID: 12097295
    [Abstract] [Full Text] [Related]

  • 3. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
    Chen TP, Chen CM, Chang HW, Wang JS, Chang WC, Hsu SI, Cho CL.
    Gynecol Oncol; 2007 Mar 01; 104(3):516-23. PubMed ID: 17079005
    [Abstract] [Full Text] [Related]

  • 4. Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma.
    Masuda TA, Inoue H, Nishida K, Sonoda H, Yoshikawa Y, Kakeji Y, Utsunomiya T, Mori M.
    Clin Cancer Res; 2003 Nov 15; 9(15):5693-8. PubMed ID: 14654553
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Sui L, Dong Y, Watanabe Y, Yamaguchi F, Sugimoto K, Tokuda M.
    Oncol Rep; 2006 Apr 15; 15(4):765-71. PubMed ID: 16525656
    [Abstract] [Full Text] [Related]

  • 6. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A, Yoshino I, Tanaka S, Sugio K, Kameyama T, Yamaguchi M, Maehara Y.
    J Clin Oncol; 2004 Oct 15; 22(20):4165-73. PubMed ID: 15483027
    [Abstract] [Full Text] [Related]

  • 7. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH, Cheng YW, Chang JT, Wu TC, Chen CY, Lee H.
    Cancer; 2007 Jul 01; 110(1):215-23. PubMed ID: 17508409
    [Abstract] [Full Text] [Related]

  • 8. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
    Voduc D, Nielsen TO, Cheang MC, Foulkes WD.
    Hum Pathol; 2008 Oct 01; 39(10):1431-7. PubMed ID: 18620730
    [Abstract] [Full Text] [Related]

  • 9. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
    Huang HY, Kang HY, Li CF, Eng HL, Chou SC, Lin CN, Hsiung CY.
    Clin Cancer Res; 2006 Jan 15; 12(2):487-98. PubMed ID: 16428491
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N, Yachida S, Okano K, Wakabayashi H, Imaida K, Kurokohchi K, Masaki T, Kinoshita H, Tominaga M, Ajiki T, Ku Y, Okabayashi T, Hanazaki K, Hiroi M, Izumi S, Mano S, Okada S, Karasawa Y, Maeba T, Suzuki Y.
    Ann Surg Oncol; 2009 Feb 15; 16(2):395-403. PubMed ID: 19034576
    [Abstract] [Full Text] [Related]

  • 11. Prognostic impact of Skp2 and p27 in human breast cancer.
    Traub F, Mengel M, Lück HJ, Kreipe HH, von Wasielewski R.
    Breast Cancer Res Treat; 2006 Sep 15; 99(2):185-91. PubMed ID: 16636894
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer.
    Radke S, Pirkmaier A, Germain D.
    Oncogene; 2005 May 12; 24(21):3448-58. PubMed ID: 15782142
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
    Osoegawa A, Yoshino I, Kometani T, Yamaguchi M, Kameyama T, Yohena T, Maehara Y.
    Cancer; 2006 Jul 01; 107(1):154-61. PubMed ID: 16721818
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.
    Chiappetta G, De Marco C, Quintiero A, Califano D, Gherardi S, Malanga D, Scrima M, Montero-Conde C, Cito L, Monaco M, Motti ML, Pasquinelli R, Agosti V, Robledo M, Fusco A, Viglietto G.
    Endocr Relat Cancer; 2007 Jun 01; 14(2):405-20. PubMed ID: 17639054
    [Abstract] [Full Text] [Related]

  • 15. The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer.
    Takanami I.
    Oncol Rep; 2005 Apr 01; 13(4):727-31. PubMed ID: 15756449
    [Abstract] [Full Text] [Related]

  • 16. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
    Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I, Takata T.
    Cancer Res; 2001 Oct 01; 61(19):7044-7. PubMed ID: 11585732
    [Abstract] [Full Text] [Related]

  • 17. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.
    Shigemasa K, Gu L, O'Brien TJ, Ohama K.
    Clin Cancer Res; 2003 May 01; 9(5):1756-63. PubMed ID: 12738731
    [Abstract] [Full Text] [Related]

  • 18. Inverse correlation between expression levels of p27 and the ubiquitin ligase subunit Skp2 in early esophageal squamous cell carcinoma.
    Fukuchi M, Masuda N, Nakajima M, Fukai Y, Miyazaki T, Kato H, Kuwano H.
    Anticancer Res; 2004 May 01; 24(2B):777-83. PubMed ID: 15161026
    [Abstract] [Full Text] [Related]

  • 19. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
    Huang CW, Lin CY, Huang HY, Liu HW, Chen YJ, Shih DF, Chen HY, Juan CC, Ker CG, Huang CY, Li CF, Shiue YL.
    Ann Surg Oncol; 2010 Mar 01; 17(3):907-22. PubMed ID: 19866239
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP.
    Clin Cancer Res; 2005 May 01; 11(9):3184-90. PubMed ID: 15867211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.